AI-generated summary
This Cochrane review pooled three randomised trials of second-generation antidepressants for seasonal affective disorder, with 204 participants. The authors report that fluoxetine was not significantly more effective than placebo, and that fluoxetine and light therapy appeared roughly equal, but evidence was limited to small trials of low quality.
- Participants
- 204
- Studies included
- 3
- Who or what was studied
- Adults with seasonal affective disorder meeting DSM criteria; average age about 40 years and about 70% female.
- Limits stated in the abstract
- The authors state the evidence is limited to small trials, adverse effect data were sparse and crude, and the overall quality of evidence is very low.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on doi.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Risk of bias, Meta-analysis, Depression, Confidence interval, Attrition, Anxiety. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.